These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 32103368)
1. In vitro Susceptibilities of Methicillin-Susceptible and Resistant Staphylococci to Traditional Antibiotics Compared to a Novel Fluoroquinolone. Fan KC; Lin J; Yannuzzi NA; Al-Khersan H; Patel NA; Maestre-Mesa J; Zaidi M; Miller D; Flynn HW J Ophthalmic Inflamm Infect; 2020 Feb; 10(1):9. PubMed ID: 32103368 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study. Tessier E; Ruffier d'Epenoux L; Lartigue MF; Chaufour L; Plouzeau-Jayle C; Chenouard R; Guérin F; Tandé D; Lamoureux C; Bémer P; Corvec S; J Antimicrob Chemother; 2024 May; 79(5):1045-1050. PubMed ID: 38507272 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of delafloxacin against highly levofloxacin-resistant invasive isolates of Streptococcus pneumoniae. Cercenado E; Loras C; Cobos A; Sanz JC Enferm Infecc Microbiol Clin (Engl Ed); 2020 Nov; ():. PubMed ID: 33190935 [TBL] [Abstract][Full Text] [Related]
5. Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections. Lee YR; Burton CE; Bevel KR J Pharm Technol; 2019 Jun; 35(3):110-118. PubMed ID: 34861007 [No Abstract] [Full Text] [Related]
6. Comparison of the Kong Y; Geng Z; Jiang G; Jia J; Wang F; Jiang X; Gu Y; Qi Z; Chu N; Huang H; Yu X Heliyon; 2023 Nov; 9(11):e21216. PubMed ID: 37954372 [TBL] [Abstract][Full Text] [Related]
7. Topical antibiotic therapy in eye infections - myths and certainties in the era of bacterial resistance to antibiotics. Aramă V Rom J Ophthalmol; 2020; 64(3):245-260. PubMed ID: 33367158 [TBL] [Abstract][Full Text] [Related]
8. Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa. Holland M; Bjanes E; Nizet V; Dillon N J Antimicrob Chemother; 2022 Feb; 77(2):433-442. PubMed ID: 34893834 [TBL] [Abstract][Full Text] [Related]
9. A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP). Horcajada JP; Salata RA; Álvarez-Sala R; Nitu FM; Lawrence L; Quintas M; Cheng CY; Cammarata S; Open Forum Infect Dis; 2020 Jan; 7(1):ofz514. PubMed ID: 31988972 [TBL] [Abstract][Full Text] [Related]
10. Establishing Kim HW; Kim JK; Park I; Lee SJ Front Med (Lausanne); 2021; 8():670199. PubMed ID: 34988087 [No Abstract] [Full Text] [Related]
11. Changes in the preoperative ocular surface flora with an increase in patient age: A surveillance analysis of bacterial diversity and resistance to fluoroquinolone. Sakisaka T; Iwasaki T; Ono T; Ueda K; Nejima R; Mori Y; Noguchi Y; Yagi A; Shoji N; Miyata K Graefes Arch Clin Exp Ophthalmol; 2023 Nov; 261(11):3231-3239. PubMed ID: 37261513 [TBL] [Abstract][Full Text] [Related]
12. The impact of oxygen content on Lv H; Zhang W; Zhao Z; Wei Y; Bao Z; Li Y; Hu Z; Deng D; Yuan W Front Microbiol; 2024; 15():1409597. PubMed ID: 39050640 [TBL] [Abstract][Full Text] [Related]
13. Visible-Light Controlled Release of a Fluoroquinolone Antibiotic for Antimicrobial Photopharmacology. Kumari P; Kulkarni A; Sharma AK; Chakrapani H ACS Omega; 2018 Feb; 3(2):2155-2160. PubMed ID: 30023825 [TBL] [Abstract][Full Text] [Related]
14. Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid. Saravolatz LD; Pawlak JM; Wegner C J Antimicrob Chemother; 2020 Sep; 75(9):2605-2608. PubMed ID: 32542310 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of gentamicin in surgical perfusion solution on cataract postoperative endophthalmitis. Ma W; Hou G; Wang J; Liu T; Tian F BMC Ophthalmol; 2022 Oct; 22(1):410. PubMed ID: 36274140 [TBL] [Abstract][Full Text] [Related]
16. Potential new fluoroquinolone treatments for suspected bacterial keratitis. Herbert R; Caddick M; Somerville T; McLean K; Herwitker S; Neal T; Czanner G; Tuft S; Kaye SB BMJ Open Ophthalmol; 2022 Jul; 7(1):. PubMed ID: 36161851 [TBL] [Abstract][Full Text] [Related]
17. Delafloxacin-Capped Gold Nanoparticles (DFX-AuNPs): An Effective Antibacterial Nano-Formulation of Fluoroquinolone Antibiotic. Abu Lila AS; Huwaimel B; Alobaida A; Hussain T; Rafi Z; Mehmood K; Abdallah MH; Hagbani TA; Rizvi SMD; Moin A; Ahmed AF Materials (Basel); 2022 Aug; 15(16):. PubMed ID: 36013845 [TBL] [Abstract][Full Text] [Related]